SUVmax provides valuable indicator of progression-free survival in stage I NSCLC patients

SUVmax (Maximum Standardized Uptake Value) may be a significant and clinically independent marker to indicate progression-free survival in stage I non-small cell lung cancer (NSCLC) patients treated with stereotactic body radiation therapy, according to research being presented at the 2013 Cancer Imaging and Radiation Therapy Symposium. This Symposium is sponsored by the American Society for Radiation Oncology and the Radiological Society of North America.

Fuente : http://www.eurekalert.org/pub_releases/2013-02/asf...